Gentile Kimberly 4
4 · Biohaven Ltd. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Biohaven Ltd.BHVN
Gentile Kimberly
SVP, Clinical Operations
Transactions
- Award
Stock Options (Right to buy)
2025-01-05+91,000→ 91,000 totalExercise: $38.64Exp: 2035-01-05→ Common Shares (91,000 underlying) - Exercise/Conversion
Common Shares
2025-01-05+3,750→ 99,719 total - Tax Payment
Common Shares
2025-01-05$38.64/sh−1,956$75,580→ 97,763 total - Award
Restricted Share Unit Award
2025-01-05+15,000→ 15,000 total→ Common Shares (15,000 underlying) - Exercise/Conversion
Restricted Share Unit Award
2025-01-05−3,750→ 11,250 total→ Common Shares (3,750 underlying)
Footnotes (5)
- [F1]No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
- [F2]The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
- [F3]Each restricted share unit represents the contingent right to receive one common share of the Issuer.
- [F4]The reporting person was granted 15,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
- [F5]Not applicable.